跳至主要内容
临床试验/CTRI/2022/07/043879
CTRI/2022/07/043879尚未招募未知

Role of Beta-blocker and Norepinephrine in the outcome of stroke

Prinicipal Investigator0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Consecutive patients with CT/MRI proven stroke within 3 days of ictus will be included

排除标准

  • Stroke due to arteriovenous malformation, aneurysm, coagulopathy,
  • bleeding disorders, tumor, trauma, patients with hepatic or renal failure, pre-existing cardiac
  • failure, heart block, renal disease, liver disease, endocrinal disease, HIV, pregnancy,
  • lactation, and those on corticosteroids, norepinephrine, immunosuppressant, chemotherapy
  • and radiotherapy will be excluded.

研究者

发起方
Prinicipal Investigator

相似试验